Bulletin
Investor Alert

New York Markets Open in:

OrganiGram Holdings Inc.

NAS: OGI

GO
/marketstate/country/us

Before the Bell

OGI
/zigman2/quotes/209289540/lastsale

$

1.52

Change

+0.03 +2.01%

Volume

Volume 432

Jul 10, 2020, 7:04 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/209289540/lastsale

Previous close

$ 1.49

$ 1.49

Change

-0.05 -3.25%

Day low

Day high

$1.47

$1.57

Open
Open: 1.54

52 week low

52 week high

$1.09

$6.95

Open

Market cap

$296.90M

Average volume

6.46M

P/E ratio

N/A

Rev. per Employee

$49,972

EPS

-0.20

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ogi

MarketWatch News on OGI

  1. OrganiGram Holdings initiated at buy with C$4 price target at Alliance Global Partners

    7:55 a.m. July 7, 2020

    - Tonya Garcia

  2. OrganiGram names current CFO Paolo De Luca as chief strategy officer

    7:03 a.m. March 4, 2020

    - Tomi Kilgore

  3. OrganiGram names current board member Derrick West as CFO

    7:02 a.m. March 4, 2020

    - Tomi Kilgore

  4. OrganiGram's stock climbs 5.4% in premarket trading

    7:57 a.m. Feb. 14, 2020

    - Tomi Kilgore

  5. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/ogi

Other News on OGI

  1. Organigram cuts workforce and production on lower demand

    12:05 p.m. July 3, 2020

    - Seeking Alpha

  2. CBD is One of the Fastest Growing Catalysts for Retailers

    8:43 a.m. June 25, 2020

    - Baystreet.ca

  3. Pot stocks rally on Aurora Cannabis reboot actions

    11:38 a.m. June 23, 2020

    - Seeking Alpha

  4. 7 Marijuana Stocks for Loyal Cannabis Bulls

    10:32 a.m. June 19, 2020

    - InvestorPlace.com

  5. 4 High-Quality Stocks To Buy That Won’t Break the Bank

    3:03 p.m. June 18, 2020

    - InvestorPlace.com

  6. Hexo Stock Still Has a Major Cash Problem

    12:05 p.m. June 18, 2020

    - InvestorPlace.com

  7. Oppenheimer Releases a Hold Rating on OrganiGram Holdings (OGI)

    7:37 p.m. June 16, 2020

    - SmarterAnalyst

  8. Will OrganiGram Stock Finally Capitalize on Cannabis 2.0?

    3:44 p.m. June 9, 2020

    - InvestorPlace.com

  9. Organigram inks dried flower deal with Canndoc

    9:01 a.m. June 9, 2020

    - Seeking Alpha

  10. Organigram (OGI) Catches Eye: Stock Jumps 11.7%

    8:58 a.m. May 19, 2020

    - Zacks.com

  11. OrganiGram: No Relief In Sight

    7:25 p.m. May 12, 2020

    - Seeking Alpha

  12. Short Sellers Up the Ante in Cannabis Stocks

    9:03 a.m. April 27, 2020

    - 247WallSt.com

  13. Guggenheim on the fence with Amgen in premarket analyst action

    7:11 a.m. April 15, 2020

    - Seeking Alpha

  14. OrganiGram Earnings: OGI Stock Falls 12% on Q2 Results

    3:27 p.m. April 14, 2020

    - InvestorPlace.com

  15. Loading more headlines...
/news/pressrelease/company/us/ogi

Press Releases on OGI

  1. CBD is One of the Fastest Growing Catalysts for Retailers

    8:32 p.m. June 25, 2020

    - Baystreet.ca

  2. Billion Dollar CBD Market Revenue Projected to Climb as Sales Increase

    2:46 p.m. June 24, 2020

    - Financial News Media

  3. Organigram Holdings Inc. Provides Corporate Updates

    6:00 a.m. June 23, 2020

    - BusinessWire - BZX

  4. US Stocks Surging Above 20days Moving Average (20SMA): $USB $OGI $BUD

    9:20 a.m. June 22, 2020

    - The Market Signal

  5. COVID Spikes a Tsunami of Cannabis Sales

    9:01 a.m. June 22, 2020

    - NetworkNewsWire

  6. COVID Spikes a Tsunami of Cannabis Sales

    9:01 a.m. June 22, 2020

    - CannabisNewsWire

  7. COVID Spikes a Tsunami of Cannabis Sales

    8:30 a.m. June 22, 2020

    - PR Newswire - PRF

  8. Organigram and Canndoc Sign International Strategic Agreement

    8:45 a.m. June 9, 2020

    - BusinessWire - BZX

  9. Organigram Rolls out Cannabis 2.0 Products to Medical Consumers

    10:48 a.m. May 28, 2020

    - BusinessWire - BZX

  10. Loading more headlines...

Rates »

Link to MarketWatch's Slice.